Mélanie Thill-Tayara
Dechert LLPDechert LLP is highly regarded for its prowess in the life sciences sector, frequently acting for leading pharmaceutical companies in high-profile merger control cases and antitrust litigation; its impressive recent highlights include securing a victory for Roche before the Paris Court of Appeal in a challenge to a fine imposed by the FCA. The team is experienced across the board of EU and competition law matters, but is particularly noted for its expertise in cartel and abuse of dominance cases, where Mélanie Thill-Tayara (who also leads the global life sciences practice) has an excellent reputation. Laurence Bary and Marion Provost are also names to note.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Multidisciplinary team that knows how to work together and see all aspects of the same contract or the same problem.’
‘The strength of this team is its ability to understand the pharmaceutical market globally, with competition specialists and market regulation specialists. Women are well represented in the team and it works closely together. Good listening skills.’
‘Mélanie Thill-Tayara, Marion Provost and Laurence Bary all stand out.’
‘Highly competent team accustomed to working together which allows them to deliver very high-quality work, and they are also able to quickly have effective contact online, even when the person responsible for the file is absent.’
‘Mélanie Thill-Tayara stands out for her strategic approach to litigation and her very good knowledge of the mysteries of the competition authorities, and Laurence Bary for her great rigour and her very good technical skills.'
Key clients
- Apple
- ArianeGroup
- Cathay Capital
- Chiesi Farmaceutici S.p.A
- Cora and Supermarchés Match
- Deutsche Bahn AG
- Mayoly Spindler
- Roche
Work highlights
- Successfully represented Apple before the Paris Court of Appeal in challenging the highest fine ever imposed by the FCA against one single company, which was over €1.1 billion for Apple alone.
- Successfully represented Roche in the context of its appeal before the Paris Court of Appeal against the more than €400 million fine initially imposed by the FCA for an abuse of collective dominance with Novartis, which was completely annulled.
- Advised Chiesi Farmaceutici S.p.A. in the merger control and FDI aspects of its US$1.4 billion acquisition of Amryt Pharma Plc., a UK-based company specializing in the development of treatments for rare diseases.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Laurence Bary
Dechert LLPPractice head
The lawyer(s) leading their teams.
Mélanie Thill-Tayara